Guo M[Author] - Search Results

Year	Number of Results
1963	1
1965	1
1971	1
1973	1
1976	1
1977	1
1978	1
1979	3
1980	1
1981	2
1982	1
1984	1
1986	4
1987	2
1988	3
1989	9
1990	10
1991	3
1992	7
1993	10
1994	9
1995	16
1996	12
1997	17
1998	16
1999	21
2000	32
2001	39
2002	45
2003	65
2004	79
2005	87
2006	94
2007	124
2008	130
2009	137
2010	178
2011	209
2012	242
2013	285
2014	347
2015	417
2016	497
2017	520
2018	594
2019	763
2020	944
2021	1014
2022	1123
2023	1228
2024	1398
2025	1493
2026	25

1

Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling.

Guo M, Yuan Z, Jin X, Li X, Deng Y, Zhou S, Niu R, Bae J, Park JB, Shi B, Yin J. Guo M, et al. Nat Commun. 2025 Sep 30;16(1):8642. doi: 10.1038/s41467-025-63796-2. Nat Commun. 2025. PMID: 41028719 Free PMC article.

2

Exosome-mediated microglia-astrocyte interactions drive neuroinflammation in Parkinson's disease with Peli1 as a potential therapeutic target.

Guo M, Guan A, Zhang M, Li H, Liu W, Wu B, Shen W, You T, Liang S, Dong Q, Yu J, Zhao Y, Cui M. Guo M, et al. Pharmacol Res. 2025 Sep;219:107908. doi: 10.1016/j.phrs.2025.107908. Epub 2025 Aug 13. Pharmacol Res. 2025. PMID: 40816423 Free article.

3

Shaping the future of probiotics, live biotherapeutic products, and fecal microbiota transplantation: 30 scientific recommendations from the CHINAGUT Conference.

Wang W, Bu N, Cao H, Chen N, Chen W, Cheng L, Cui B, Dai L, Gao H, Guo M, He X, Hu J, Jiang C, Jiang X, Li J, Li P, Li W, Liao W, Liu H, Liu J, Liu L, Liu S, Liu X, Lv M, Ma Y, Man C, Pi Z, Ren Q, Sang L, Sun Z, Suo H, Tan Y, Tao W, Wang G, Wang J, Wang L, Wang X, Wang X, Wang Y, Wu K, Wu R, Wu Z, Xiao X, Xiang B, Yang S, Yi H, Yu H, Yu J, Zeng Y, Zhai H, Zhai Q, Zhang C, Zhang G, Zhang J, Zhang W, Zhao F, Zhao L, Zhou H, Zhu L, Lan C, Zhang H, Zhu S, Zhang F. Wang W, et al. Among authors: guo m. Imeta. 2025 Oct 2;4(5):e70083. doi: 10.1002/imt2.70083. eCollection 2025 Oct. Imeta. 2025. PMID: 41112050 Free PMC article.

4

Oxidative stress-induced ZEB1 acetylation drives a hybrid epithelial-mesenchymal phenotype and promotes lung metastasis in triple-negative breast cancer.

Guo M, Wang YJ, Shi J, Cao LX, Ou Y, Jia X, Qi CC, Li ZX, Liu YX, Zuo SY, Shuai QY, Yu TW, Hu HY, Chen X, Feng MD, Xue Y, Wang H, Sun PQ, Liu L, Shi Y, Yang S. Guo M, et al. Redox Biol. 2025 Oct;86:103834. doi: 10.1016/j.redox.2025.103834. Epub 2025 Aug 19. Redox Biol. 2025. PMID: 40850192 Free PMC article.

5

Signaling reprogramming via Stat3 activation unravels high-fidelity human post-implantation embryo modeling.

Chen C, Wu J, Wang X, Chang L, Wang K, Wu K, Guo M, Li H, Sun F, Jiang X, Ma Y, Pan G, Xiao Z, Silva JCR. Chen C, et al. Among authors: guo m. Cell Stem Cell. 2025 Oct 2;32(10):1528-1544.e10. doi: 10.1016/j.stem.2025.08.011. Epub 2025 Sep 16. Cell Stem Cell. 2025. PMID: 40961945

6

The Roles of Neutrophil Cells in the Pathogenesis of Fibrosis: Mechanisms for Disease Progression.

Zheng Y, Xu H, Guo M, Yu Y, Wang J. Zheng Y, et al. Among authors: guo m. FASEB J. 2025 Sep 15;39(17):e70992. doi: 10.1096/fj.202501715R. FASEB J. 2025. PMID: 40875188 Review.

7

Inhibition of UBE2N promotes the clearance of mutant HTT (huntingtin) in HD knock-in mice.

Ou K, Wang X, Guo M, Li D, Zhang C, Chen L, Hou J, Jia Q, Zhu L, Yang S, Li S, Li XJ, Yin P. Ou K, et al. Among authors: guo m. Autophagy. 2025 Aug 16. doi: 10.1080/15548627.2025.2549109. Online ahead of print. Autophagy. 2025. PMID: 40818063

8

Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial.

He Y, Mi N, Cheng Z, Xue H, Han J, Wang H, Wang H, Wu J, Shi X, Zhao S, Duan B, Zhu Y, Zhou Y, Li F, Wang X, Ling H, Wang S, Li Q, Jiang F, Yang M, Bing S, Zheng Q, Ning J, Guo M, Bu Y, Guan L, Li Y, Yang L, Guo W, Pan H, Li X. He Y, et al. Among authors: guo m. Lancet Diabetes Endocrinol. 2025 Oct;13(10):863-873. doi: 10.1016/S2213-8587(25)00196-2. Epub 2025 Aug 22. Lancet Diabetes Endocrinol. 2025. PMID: 40854315 Clinical Trial.

9

A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression.

Yuan S, Ming DJ, He J, Liu MY, He SH, Weng H, Xi S, Zhang JH, Shi MH, Cui JL, Li LY, Zhang H, Wang DQ, Li F, Guo MM, Cai Y, Tang SD, Wang SY, Wang XH, Zeng XT, Hu H. Yuan S, et al. Among authors: guo mm. Proc Natl Acad Sci U S A. 2025 Oct 28;122(43):e2510386122. doi: 10.1073/pnas.2510386122. Epub 2025 Oct 23. Proc Natl Acad Sci U S A. 2025. PMID: 41129231

10

Effects of esketamine on electrophysiology and metabolic reprogramming in brain organoids: insights into antidepressant mechanisms.

Li M, Duan W, Hao X, Li S, Wang C, Liang Y, Hu Z, Ma D, Guo M, Zuo C, Wang Z, Feng Y, Hao C, Qi S, Sun Y, Tang M, Mao C, Hashimoto K, Xu Y, Yuan J, Yang J, Shi C. Li M, et al. Among authors: guo m. Mol Psychiatry. 2025 Dec;30(12):6107-6118. doi: 10.1038/s41380-025-03198-4. Epub 2025 Aug 30. Mol Psychiatry. 2025. PMID: 40885845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,992 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,992 results

Results by year